Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
152 Cards in this Set
- Front
- Back
what part of the lymph node is the site of B cell proliferation |
follicle
|
|
what part of the lymph node contains T cells and HEVs
|
paracortex
|
|
what cells make up the PALS
|
T cells
|
|
splenic dysfunction greatly increases risk of infection via what 4 organisms
|
Salmonella, S. pneumoniae, H. influenzae, and N. meningitidis
("SHiNS") |
|
organ containing Hassall's corpuscles
|
thymus
|
|
type of immunity consisting of neutrophils, macrophages, dendritic cells, NK cells, and complement
|
innate
|
|
type of immunity consisting of T cells, B cells, and antibodies
|
adaptive
|
|
what gene encodes MHC I and II
|
HLA (human leukocyte antigen)
|
|
which interleukins induce the transformation of a helper T cell into TH1 and TH2 cells
|
IL-12 induces Th1 cell formation
IL-4 induces Th2 cell formation |
|
what are the antigen presenting cells
|
macrophages, dendritic cells, and B cells
|
|
what are the costimulatory signals required for CD4 cell activation
|
B7 and CD28
|
|
what cytokines do Th1 cells secrete
|
IL-2 and IFN-y
|
|
structural portion of the antibody that binds antigens and determines the idiotype
|
Fab
|
|
MOST abdundant immunoglobulin
|
IgG
|
|
immunoglobulin responsible for opsonization
|
IgG
|
|
major immunoglobulin in secodary (delayed) responses to antigens
|
IgG
|
|
immunoglobulin found in tears, saliva, mucus, and breast milk
|
IgA
|
|
major immunoglobulin in primary (immediate) responses to antigens
|
IgM
|
|
mature B lymphocytes always express what 2 immunoglobulins
|
IgM and IgD
|
|
immunoglobulin responsible for type 1 hypersensitivity and binds to mast cells and basophils
|
IgE
|
|
what component is responsible for opsonization
|
C3b
|
|
what component is responsible for anaphylaxis
|
C3a and C5a
|
|
defective complement enzyme that causes hereditary angioedema
|
C1 esterase inhibitor
|
|
deficiency of which complement leads to severe, recurrent pyogenic infection
|
C3
|
|
deficiency of C5-C8 increases risk for what
|
bacteremia secondary to Neisseria infection
|
|
cytokine that mediates septic shock
|
TNF-a
|
|
interleukin that causes fever
|
IL-1
|
|
interleukin that stimulates T cells
|
IL-2
|
|
interleukin that stimulates bone marrow
|
IL-3
|
|
interleukin that stimulates IgE production
|
IL-4
|
|
interleukin that stimulates IgA production
|
IL-5
|
|
interleukin that recruits neutrophils
|
IL-8
|
|
interleukin that activates NK cells
|
IL-12
|
|
cytokine that activates macrophages
|
IFN-y
|
|
interleukin that stimulates eosinophils
|
IL-5
|
|
interleukin secreted by regulatory T cells that mediates the inflammatory response
|
IL-10
|
|
CD receptor for EBV
|
CD-21
|
|
process in which self-reactive T cells become nonreactive without a costimulatory molecule
|
anergy
|
|
What is the FIRST immunoglobulin produced in ALL types of hypersensitivity reaction-- no exceptions
|
IgM
|
|
Primary site of drainage for the upper limb and lateral breast
|
axillary nodes
|
|
Primary site of drainage for the stomach
|
celiac nodes
|
|
Primary site of drainage for the rectum above the pectinate line
|
internal iliac nodes
|
|
Primary site of drainage for the anal canal below the pectinate line
|
superficial inguinal nodes
|
|
Primary site of drainage for the testes
|
para-aortic nodes (aka lumbar nodes from the superficial and deep plexuses)
|
|
which disease(s) are associated with the HLA subtype A3
|
hemochromatosis
|
|
which disease(s) are associated with the HLA subtype B27
|
Psoriasis, Ankylosing spondylitis, IBS, and Reiter's syndrome
("PAIR") |
|
which disease(s) are associated with the HLA subtype B8
|
Graves disease
|
|
which disease(s) are associated with the HLA subtype DR2
|
MS, hay fever, SLE, Goodpasture's
|
|
which disease(s) are associated with the HLA subtype DR3
|
type 1 diabetes
|
|
which disease(s) are associated with the HLA subtype DR4
|
Rheumatoid arthritis and type 1 diabetes
|
|
which disease(s) are associated with the HLA subtype DR5
|
Pernicious anemia and Hashimoto's thyroiditis
|
|
which disease(s) are associated with the HLA subtype DR7
|
nephrotic syndrome (responsive to seroids)
|
|
Th1 cells are inhibited by what interleukin
|
IL-10
|
|
Th2 cells are inhibited by what cytokine
|
IFN-y
|
|
which T helper cells regulate cell-mediated immunity
|
Th1 cells
|
|
which T helper cells regulate humoral immunity
|
Th2 cells
|
|
which immunoglobulin is shaped as a pentamer
|
IgM
|
|
complement protein responsible for neutrophil chemotaxis
|
C5a
|
|
pathogenesis of type I hypersensitivity
|
foreign antigen binds to IgE and present to a mast cell or basophil- this triggers the release of histamine causing a rapid allergic reaction
|
|
which conditions have type I hypersensitivity
|
anaphylaxis (eg. bee sting or food allergy)
atopic disorders (i.e. rhinitis, hay fever, eczema, hives, asthma) |
|
pathogenesis of type II hypersensitivity
|
antibody mediated: IgM and IgD bind to the foreign antigen and induce lysis or phagocytosis (via macrophages and neutrophils)
|
|
which type of hypersensitivity is elicited by a radioimmunosorbent assay
|
type 1 hypersensitivity
|
|
which type of hypersensitivity is elicited by a Coombs test
|
type II hypersensitivity
|
|
which conditions have type II hypersensitivity
|
hemolytic anemia
pernicious anemia ITP erythroblastosis fetalis acute hemolytic transfusion rxn rheumatic fever goodpastures bullous pemphigoid pemphigus vulgaris graves disease myasthenia gravis |
|
pathogenesis of type III hypersensitivity
|
antigen-antibody immune complexes (usually IgG) are formed when presented with a foreign antigen- this activates complement proteins
|
|
immunofluorescent staining can test for which type of hypersensitivity
|
type III hypersensitivity
|
|
which conditions have type III hypersensitivity
|
SLE
rheumatoid arthritis polyarteritis nodosum poststreptococcal glomerulonephritis serum sickness arthus reaction hypersensitivity pneumonitis (aka farmer's lung) |
|
what is serum sickness
|
a condition normally caused by drugs (not serum) in which antibodies to a foreign protein are produced and leads to immune complex deposits in the membranes causing tissue damage
|
|
time frame for serum sickness to develop
|
5 days after exposure to foreign drug
|
|
what is the arthus reaction
|
intradermal injection of an antigen induces antibodies which forms immune complexes in the skin
|
|
time frame for an arthus reaction to develop
|
24 hours after injection
|
|
pathogenesis of type IV hypersensitivity
|
a delayed T-cell mediated response to foreign antigens- causes the release of lymphokines which activates macrophages (No antibodies or immune complexes are involved!)
|
|
patch test (eg. PPDs) test for which type of hypersensitivity
|
type IV hypersensitivity
|
|
which conditions exhibit type IV hypersensitivity
|
type 1 diabetes mellitus
MS Guillain-Barre Hashimoto's thyroiditis graft versus host disease PPD (TB) contact dermatitis (i.e. poison ivy or nickel allergy) |
|
antinuclear autoantibodies (ANA) suggest what disease
|
nonspecific for SLE
|
|
anti-dsDNA and anti-Sm antibodies suggest what disease
|
specific for SLE
|
|
anti-histone antibodies suggest what disease
|
drug-induced SLE
|
|
Anti-IgG (Fc portion) antibodies suggest what disease
|
rheumatoid arthritis
|
|
Anti-centromere antibodies suggest what disease
|
scleroderma (CREST)
|
|
anti-Scl70 antibodies suggest what disease
|
scleroderma (diffuse)
|
|
antimitochondrial antibodies suggest what disease
|
primary biliary cirrhosis
|
|
antigliadin and antiendomysial antibodies suggest what disease
|
celiac disease
|
|
anti-basement membrane (type IV collagen) antibodies suggest what disease
|
Goodpasture's syndrome
|
|
anti-desmoglein antibodies suggest what disease
|
pemphigus vulgaris
|
|
antimicrosomal and antithyroglobulin antibodies suggest what disease
|
Hashimoto's thyroiditis
|
|
anti-Jo-1 antibodies suggest what disease
|
polymyositis or dermatomyositis
|
|
anti-SSA and anti-SSB antibodies suggest what disease
|
Sjogrens
|
|
anti-U1 RNP antibodies suggest what disease
|
mixed connective tissue disease
|
|
anti-smooth muscle antibodies suggest what disease
|
autoimmune hepatitis
|
|
anti-glutamate decarboxylase antibodies suggest what disease
|
type I diabetes
|
|
c-ANCA antibodies suggest what disease
|
Wegener's granulomatosis
|
|
p-ANCA antibodies suggest what disease
|
polyangiitis
|
|
anti-phospholipid antibodies suggest what condition
|
DVT
|
|
anti-GpIIb/IIIa antibodies suggest what disease
|
ITP
|
|
disease caused by a defect in BTK (tyrosine kinase gene) leading to a block in B-cell differentiation
|
Bruton's agammaglobulinemia
|
|
genetic mode of inheritance of Bruton's
|
X-linked recessive
|
|
Is Bruton's more common in boys or girls
|
boys (because it's X-linked recessive)
|
|
1 year old boy presents with recurrent bacterial infections; labs reveal decreased levels of all immunoglobulins and decreased number of B cells
|
Bruton's agammaglobulinemia
|
|
disease caused by a defective CD40L on the helper T cells leading to the inability of class switching
|
Hyper-IgM syndrome
|
|
8 month old presents with recurrent severe pyogenic infections; labs reveal very low levels of all immunoglobulins except IgM (which are increased)
|
hyper-IgM syndrome |
|
disease characterized by defect in isotype switching
|
Selective Ig deficiency
|
|
MOST common selective Ig deficiency
|
IgA deficiency
|
|
8 month old infant presents with recurrent sinus and lung infections, milk allergies, and diarrhea; he also has anaphylactic reactions on exposure to blood products containing a certain immunoglobulin
|
selective IgA deficiency
|
|
disease caused by a defect in B-cell maturation
|
common variable immunodeficiency (CVID)
|
|
30 y/o patient presents with malaise, lymphadenopathy, and an unintentional 15lb weight loss over the last 6 months; PMH is positive for recurrent sinus and pulmonary infections as well as SLE; lab values reveal decreased plasma cells and immunoglobulins; a preliminary diagnosis of lymphoma is made; what is the underlying condition that can explain not only the current presentation but also the PMH?
|
common variable immunodeficiency (CVID) |
|
disease characterized by a gene deletion leading to a failure of the development of the 3rd and 4th pharyngeal pouches
|
DiGeorge syndrome (thymic aplasia)
|
|
gene deletion in DiGeorge syndrome
|
22q11 deletion
|
|
young child presents with tetany; cultures for C. tetani are negative; PMH is positive for recurrent viral and fungal infection as well as a congenital heart defect; lab values show decreased levels of PTH; xray has an absent thymic shadow
|
DiGeorge syndrome
|
|
2 organs MOST affected directly by DiGeorge syndrome
|
parathyroids and thymus both fail to develop (leading to tetany and T-cell deficiency)
|
|
2 congenital heart defects associated with DiGeorge syndrome
|
truncus arteriosus and tetralogy of fallot
|
|
disease caused by a failure to produce IFN-y causing an inability of neutrophils to respond to chemotaxis
|
Hyper-IgE syndrome (aka Job's syndrome)
|
|
teenager presents with very coarse facial features and eczema; PMH is positive for recurrent staphylococcal abscesses and the patient still has most of their baby teeth; lab values reveal increased levels of a certain immunoglobulin
|
Hyper-IgE syndrome (Job's syndrome)
|
|
this disease can be caused by 1 of 3 things: either a defect in the IL-2 receptors, an adenosine deaminase deficiency, or a failure to synthesize MHCII antigens
|
Severe Combined immunodeficiency (SCID)
|
|
MOST common cause of SCID and why
|
defect in IL-2 receptor because it's an X-linked condition
|
|
treatment of SCID
|
bone marrow transplant
|
|
disease caused by a defect in DNA repair enzymes causing an inactivation of tumor suppressor genes
|
ataxia-telangiectasia
|
|
patient presents with ataxia, spider angiomas on the face, recurrent sinus/lung infections, and milk allergies; labs reveal decreased levels of IgA
|
ataxia-telangiectasia
|
|
patient presents with purpura on the skin and eczema; PMH is positive for recurrent infections; labs reveals increased IgE and IgA but decreased IgM
|
Wiskott-Aldrich syndrome
|
|
disease caused by a defect in the LFA-1 integrin protein (CD18) on phagocytes
|
type 1 leukocyte adhesion deficiency
|
|
patient presents with recurrent non-purulent bacterial infections and a delayed separation of the umbilicus; labs show neutrophilia
|
type 1 leukocyte adhesion deficiency
|
|
disease caused by a defect in microtubular function causing decreased phagocytosis
|
Chediak-Higashi syndrome |
|
patient presents complaining of numbness and tingling sensation in his extremities; PMH is positive for recurrent staph and strep infection; during the PE, it's noted that the patient has partial areas of albinism
|
Chediak-Higashi syndrome
|
|
disease caused by a lack of NADPH oxidase
|
chronic granulomatous disease
|
|
a negative nitroblue tetrazolium dye reduction test suggests what disease
|
chronic granulomatous disease
|
|
which organisms in particular are people with chronic granulomatous disease susceptible to
|
catalase positive organisms (i.e. S. aureus, E. coli, and Aspergillus)
|
|
pathogensis of hyperacute graft rejection
|
antibody mediated (type II hypersensitivity) against donor tissue
|
|
time frame for hyperacute graft rejection
|
occurs within minutes
|
|
pathogenesis of acute graft rejection
|
cell-mediated due to cytotoxic T cells reacting against foreign MHC
|
|
time frame for acute rejection
|
occurs within weeks
|
|
DOC to help reverse acute graft rejection
|
cyclosporine
|
|
pathogenesis of chronic graft rejection
|
T-cell and antibody-mediated vascular damage of donor tissue leading to fibrosis (irreversible)
|
|
time frame for chronic graft rejection
|
months to years
|
|
condition characterized by grafted immunocompetent T cells proliferating in response to foreign tissue and thus rejecting it; observable signs will include a maculopapular rash, jaundice, hepatosplenomegaly, and diarrhea
|
graft-versus-host disease
|
|
this drug acts by inhibiting calcineurin and thus preventing the production of IL-2
|
cyclosporine
|
|
the nephrotoxicity of cyclosporine can be prevented by administering what drug
|
mannitol
|
|
this drug is usually combined with cyclosporine to help treat the immunosuppression after a kidney transplant
|
sirolimus (aka rapamycin)
|
|
SE of sirolimus
|
hyperlipidemia, thombocytopenia, leukopenia
|
|
monoclonal antibody with high affinity for IL-2 receptor
|
daclizumab
|
|
MOA of azothioprine
|
precursor of 6-mercaptopurine that blocks the metabolism of purines
|
|
major SE of azothioprine
|
bone marrow suppression
|
|
drug that is contraindicated in people taking azothioprine post-kidney transplant
|
allopurinol because mercaptopurine is metabolized by xanthine oxidase which is inhibited by allopurinol
|
|
monoclonal antibody with high affinity for CD3
|
muromonab (OKT3)
|
|
Filgrastim and Sargramostin are used for what
|
to help replenish bone marrow
|
|
treatment of chronic granulomatous disease
|
IFN-y
|
|
IFN-B can be used to help treat what disease
|
multiple sclerosis
|
|
hypothesized MOA of IFN-B
|
inhibition of T cell activation/proliferation and inhibition of leukocyte migration across the BBB
|
|
infliximab and adalimumab have high affinity for what
|
TNF-alpha
|
|
abciximab has a high affinity for what
|
GpIIb/IIIa
|
|
trastuzumab has a high affinity for what
|
erb-B2
|
|
trastuzumab can be used to help treat what
|
breast cancer that over-expresses HER-2
|
|
infliximab and adalimumab can be used to treat what
|
Crohn's disease, rheumatoid arthritis, and psoriasis
|
|
which hypersensivity activates complement
|
type III
|